EO-3021 is a Claudin 18.2 antibody-drug conjugate ... Elevation Oncology cannot guarantee future events, results, actions, levels of activity, performance or achievements, and the timing and ...
Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback